文献速递神经MR

利用扩散与灌注MRI影像组学及二代测序预测异柠檬酸脱氢酶野生型胶质母细胞瘤的核心信号通路

Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
PubMed 文献 · Radiology · 2019-12-17

本研究基于120例胶质瘤患者的扩散与灌注MRI影像组学特征及二代测序数据构建模型,预测IDH野生型胶质母细胞瘤的核心信号通路。验证集中联合模型预测RTK、P53和视网膜母细胞瘤1通路的AUC分别为0.88、0.76和0.81。结论认为扩散与灌注加权MRI影像组学模型有助于表征核心信号通路并可能指导靶向治疗。

要点

  • 联合扩散与灌注MRI影像组学、年龄和位置的模型可预测IDH野生型胶质母细胞瘤的RTK、P53和视网膜母细胞瘤1通路。
  • 验证集中联合模型预测RTK、P53和视网膜母细胞瘤1通路的AUC分别为0.88、0.76和0.81。
  • 训练集中联合模型在RTK和视网膜母细胞瘤通路预测上优于解剖成像模型(P=.03),在P53通路预测上优于灌注成像模型(P=.04)。

核心结论

  • 扩散与灌注加权MRI影像组学模型有助于表征IDH野生型胶质母细胞瘤的核心信号通路,并可能指导靶向治疗。

研究设计与样本

  • 回顾性研究,训练集85例(51岁±13;43例男性),验证集35例IDH野生型胶质母细胞瘤患者(56岁±12;19例女性),共120例。
  • 影像组学模型基于2017年3月至2019年2月期间接受二代测序及解剖、扩散和灌注加权成像的胶质瘤患者构建。
  • 验证集患者来自注册研究(ClinicalTrials.gov NCT02619890)的回顾性分析。
  • 特征选择采用t检验、最小绝对收缩和选择算子惩罚及随机森林。
  • 联合影像组学特征、年龄和位置,以受试者工作特征曲线下面积(AUC)评估对RTK、P53和视网膜母细胞瘤1通路的预测性能。

诊断标准与关键数值

  • 影像组学模型在RTK通路识别71个特征,P53通路17个特征,视网膜母细胞瘤通路35个特征。
  • 验证集中联合模型预测RTK通路的AUC为0.88(95%CI:0.74,1)。
  • 验证集中联合模型预测P53通路的AUC为0.76(95%CI:0.59,0.92)。
  • 验证集中联合模型预测视网膜母细胞瘤通路的AUC为0.81(95%CI:0.64,0.97)。

临床应用与阅片要点

  • 作者认为扩散与灌注加权MRI影像组学模型可帮助表征核心信号通路,并可能指导IDH野生型胶质母细胞瘤的靶向治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Next-generation sequencing (NGS) enables highly sensitive cancer genomics analysis, but its clinical implications for therapeutic options from imaging-based prediction have been limited. Purpose To predict core signaling pathways in isocitrate dehydrogenase (IDH) wild-type glioblastoma by using diffusion and perfusion MRI radiomics and NGS. Materials and Methods The radiogenomics model was developed by using retrospective patients with glioma who underwent NGS and anatomic, diffusion-, and perfusion-weighted imaging between March 2017 and February 2019. For testing model performance in predicting core signaling pathway, patients with IDH wild-type glioblastoma from a retrospective analysis from a registry (ClinicalTrials.gov NCT02619890) were evaluated. Radiogenomic feature selection was performed by using t tests, least absolute shrinkage and selection operator penalization, and random forest. Combining radiogenomic features, age, and location, the performance of predicting receptor tyrosine kinase (RTK), tumor protein p53 (P53), and retinoblastoma 1 pathways was evaluated by using the area under the receiver operating characteristic curve (AUC). Results There were 120 patients (52 years ± 13 [standard deviation]; 61 women) who were evaluated. Eighty-five patients (51 years ± 13; 43 men) were in the training set and 35 patients with IDH wild-type glioblastoma (56 years ± 12; 19 women) were in the validation set. Radiogenomics model identified 71 features in the RTK, 17 features in P53, and 35 features in the retinoblastoma pathway. The combined model showed better performance than anatomic imaging-based prediction in the RTK (P = .03) and retinoblastoma (P = .03) and perfusion imaging-based prediction in the P53 pathway (P = .04) in the training set. AUC values of the combined model for the prediction of core signaling pathways were 0.88 (95% confidence interval [CI]: 0.74, 1) for RTK, 0.76 (95% CI: 0.59, 0.92) for P53, and 0.81 (95% CI: 0.64, 0.97) for retinoblastoma in the validation set. Conclusion A diffusion- and perfusion-weighted MRI radiomics model can help characterize core signaling pathways and potentially guide targeted therapy for isocitrate dehydrogenase wild-type glioblastoma. © RSNA, 2019 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Park JE, Kim HS, Park SY, et al. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma. Radiology. 2019. PMID: 31845844. doi:10.1148/radiol.2019190913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。